1. Abdi, E. A., Kamitomo, V. J., McPherson, T. A., Konrad, M. W., Inque, M., and Tan, Y. H., 1986, Extended phase I study of human ß-interferon in human cancer, Clin. Invest. Med. 9:33–40.
2. Abdulhay, G., DiSaia, P. J., Blessing, J. A., and Creasman, W. T., 1985, Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: A Gynecologic Oncology Group study. Am. J. Obstet. Gynecol. 152:418–423.
3. Abrams, D. I., and Volberding, P. A., 1986, Alpha interferon therapy of AIDS-associated Kaposi’s sarcoma, Semin. Oncol. 13 (Suppl. 2):43–47.
4. Ainslie, J., Burdon, J. G. W., Henderson, M. M., Ilbery, P. L. T., and Matthews, J. P., 1983, The use of levamisole as an adjunct to chemotherapy and radiotherapy in the treatment of small cell carcinoma of the lung, Med. J. Aust. 2:285–287.
5. Aisner, J., Weinberg, V., Perloff, M., Weiss, R., Perry, M., Korzun, A., Ginsberg, S., and Holland, J. F., 1987, Chemotherapy versus chemoimmunotherapy (CAP v CAFVP v CMF each ± MER) for metastatic carcinoma of the breast: A CALGB study, J. Clin. Oncol. 5:1523–1533.